Study guide
Fungal, amoebic and herpetic keratitis
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Fungal, amoebic and herpetic keratitis
Key Takeaways Explain This Topic AI
Vegetative trauma and contact-lens water exposure suggest different infectious differentials but do not prove the organism.
Natamycin has trial support for filamentous fungal keratitis, while Acanthamoeba requires a sustained specialist treatment plan.
HSV epithelial disease, stromal inflammation and VZV disease require different antiviral and anti-inflammatory decisions.
Last updated: October 2026
4. Fungal Keratitis: Filamentous Moulds vs Yeasts
Fungal keratitis accounts for a significant proportion of infectious keratitis in agricultural regions, tropical climates, and immunocompromised hosts.
Filamentous Keratitis ( Fusarium , Aspergillus )
Pathogenesis : Fungal hyphae penetrate vertically through intact collagen lamellae into deep stroma and Descemet membrane, explaining poor response to superficial debridement and high recurrence rates.
Medical Therapy : Natamycin 5% ophthalmic suspension is the polyene drug of choice, superior to voriconazole for filamentous keratitis ( Fusarium in particular, as demonstrated by the MUTT I trial). It binds fungal ergosterol, increasing cell membrane permeability. Topical voriconazole or systemic antifungal treatment may be selected by a specialist according to organism and extension. MUTT II did not show an overall benefit from routinely adding oral voriconazole in severe filamentous ulcers and found more adverse events; deep invasion alone is not an automatic oral-voriconazole prescription.
Yeast Keratitis ( Candida albicans )
Medical Therapy : Topical Amphotericin B 0.15% (polyene) is the first-line agent, supplemented by topical Voriconazole 1% or oral Fluconazole (200 mg daily).
5. Acanthamoeba Keratitis
Acanthamoeba is a ubiquitous, free-living protozoan that exists in two forms: a motile, infective trophozoite and a dormant, highly resilient double-walled cyst (resistant to chlorine, desiccation, and freezing).
Clinical Presentation and Progression
Risk Factors : Contact lens wearers who use domestic tap water for lens care, wear lenses in swimming pools or hot tubs, or use homemade saline solutions.
Hallmark Symptom : Excruciating, severe ocular pain out of proportion to clinical signs , driven by perineural invasion.
Clinical Staging :
Early Phase : Punctate epithelial erosions, microcystic epitheliopathy, and pseudo-dendrites (frequently misdiagnosed as Herpes simplex virus).
Intermediate Phase : Radial keratoneuritis (infiltrates tracking along corneal nerves, characteristic) and limbitis.
Late Phase : Coalescence into a full-thickness ring infiltrate (annular stromal abscess) , progressive stromal melting, sclerokeratitis, and persistent anterior uveitis.
Diagnostic Techniques
In Vivo Confocal Microscopy (IVCM) : Rapid non-invasive optical biopsy visualising bright, highly reflective, double-walled polygonal or spherical cysts ( 10 – 25 μ m 10–25\,\mu\text{m} 10–25 μ m ) within the epithelial and stromal layers.
Culture : Non-nutrient agar (NNA) seeded with a lawn of heat-killed E. coli ; trophozoites leave clear migratory feeding tracks visible under low-power light microscopy within 2 to 7 days.
Medical Pharmacotherapy
Antiamoebic treatment is prolonged and specialist-led. The EU-authorised Akantior formulation contains polihexanide 0.8 mg/mL ( 0.08% ) and uses a labelled intensive schedule followed by tapering. Other specialist protocols use biguanides such as PHMB or chlorhexidine, sometimes with a diamidine. Those concentrations and schedules are not interchangeable, and combination therapy is not required by every regimen.
Treatment intensity and duration depend on the selected preparation, clinical response and specialist monitoring. Recrudescence can occur because cysts persist; do not set one unverified minimum duration for all patients. Reassess persistent inflammation for active infection, toxicity and associated scleritis.
6. Viral Keratitis: Herpes Simplex Virus (HSV)
Herpes simplex virus type 1 (HSV-1) establishes primary mucosal infection before undergoing retrograde axonal transport along sensory nerve branches to reside in lifelong latency within the sensory trigeminal (Gasserian) ganglion. Periodic viral reactivation travels anterograde to cause recurrent ocular disease.
1. Epithelial Keratitis (Active Replicative Infection)
Biomicroscopy : True dendritic ulcer —an arborising, linear branching epithelial defect with swollen margins and characteristic terminal bulbs . Fluorescein stains the central ulcer bed where basement membrane is exposed; rose bengal or lissamine green stains the devitalised, virus-laden epithelial cells at the ulcer periphery.
Geographic (Amoeboid) Ulcer : A broad, irregularly shaped epithelial ulcer with scalloped dendritic margins, classically precipitated by the inappropriate administration of topical corticosteroids.
Treatment : Topical Ganciclovir 0.15% gel (5 times daily until healed, then 3 times daily for 7 days) or topical Aciclovir 3% ointment; or systemic oral Aciclovir 400 mg 5 times daily (or Valaciclovir 500 mg BD). Topical corticosteroids are strictly contraindicated in active epithelial keratitis!
2. Stromal Keratitis: Immune Disciform vs Necrotising
Immune Stromal (Disciform) Keratitis : Stromal inflammation may be predominantly immune mediated, while endotheliitis can involve active viral infection. Distinguish epithelial, stromal and endothelial disease when selecting antiviral and steroid treatment. Biomicroscopy demonstrates a discrete, round/oval zone of stromal oedema with overlying intact epithelium, keratic precipitates (KPs) often beneath the area of oedema, and Descemet folds, without significant stromal necrosis. Management: use a specialist-selected topical corticosteroid with appropriate antiviral coverage and close epithelial/pressure review. The taper follows inflammatory response. Antiviral route and dose depend on epithelial disease, active endotheliitis versus suppression, renal function and local protocol; an oral suppressive dose is not a universal treatment for active infection.
Necrotising Stromal Keratitis : Direct active viral invasion combined with destructive host immune response. Features dense, white, suppurative stromal infiltrates, severe tissue necrosis, ulceration, and rapid corneal thinning. Requires high-dose systemic antiviral therapy (oral aciclovir 800 mg 5 times daily or valaciclovir 1000 mg TDS) combined judiciously with topical steroids once epithelial closure is secure.
Summary of Herpetic Eye Disease Study (HEDS) Milestones
HEDS Trial Component Clinical Question Investigated Core Landmark Finding
HEDS I (Stromal Keratitis) Efficacy of topical steroids in active stromal keratitis Topical prednisolone combined with topical trifluridine significantly accelerated resolution and reduced treatment failure compared to placebo
HEDS I (Oral Aciclovir) Benefit of oral aciclovir added to topical steroids + antiviral Oral aciclovir offered no statistically significant additional clinical benefit in patients already receiving topical steroids and topical antivirals
HEDS II (Prophylaxis) Long-term oral aciclovir in preventing recurrent HSV disease Oral aciclovir 400 mg twice daily for 12 months reduced the rate of recurrent any ocular HSV by 41% , and reduced recurrent stromal keratitis by 50%
7. Varicella Zoster Virus: Herpes Zoster Ophthalmicus (HZO)
Varicella zoster virus (VZV) reactivates from the ophthalmic division ( V 1 V_1 V 1 ) of the trigeminal ganglion, producing a painful dermatomal vesicular eruption usually respecting the facial midline; atypical or disseminated presentations require broader assessment.
Hutchinson's Sign : Vesicular involvement of the tip, ala, or side of the nose—innervated by the external nasal branch of the nasociliary nerve ( V 1 V_1 V 1 )—predicts a 3- to 4-fold elevated risk of ocular involvement (corneal inflammation, anterior uveitis, glaucoma).
Corneal Pseudodendrites : Unlike HSV, HZO produces pseudodendrites (microdendrites): elevated, mucous epithelial plaques with blunt, tapered ends, lacking terminal end-bulbs, which stain minimally with fluorescein but intensely with rose bengal.
Other Ocular Features : Nummular stromal keratitis, disciform keratitis, neurotrophic keratopathy (secondary to sensory denervation), lipid keratopathy, and post-herpetic neuralgia (PHN).
Therapy : Oral Aciclovir 800 mg 5 times daily , Valaciclovir 1000 mg TDS , or Famciclovir 500 mg TDS for 7 to 10 days, started promptly, ideally within 72 hours of rash onset. Later treatment can still be appropriate with ongoing lesions, ocular involvement or immunosuppression. Antivirals do not guarantee prevention of post-herpetic neuralgia; adjust systemic dosing for renal function and the clinical context.
Sources: EMA Akantior , MUTT II and AAO bacterial keratitis .